Newsletter

Subscribe and recieve updates on this company.

Text STOCKS to 72727 for mobile alerts

We are excited to present Bionomics Ltd. (OTC: BNOEF).

Full DD Report for BNOEF

You must become a subscriber to view this report.


Recent News from (OTC: BNOEF)

Commencement of BNC210 Phase 2 Clinical Trial for the Treatment of Agitation
Treatment of agitation in the elderly in hospital and nursing home settings represents a rapid potential path to market for BNC210 No currently approved treatments and significant unmet medical need Trial designed for rapid recruitment with results anticipated first quarter calend...
Source: PR Newswire
Date: May, 24 2018 09:00
VIDEO: Bionomics Limited CEO & Managing Director Dr. Deborah Rathjen Featured in OTCQX Video Series
NEW YORK , May 18, 2018 /PRNewswire/ -- Bionomics Limited (ASX: BNO, OTCQX: BNOEF) CEO & Managing Director Dr. Deborah Rathjen was interviewed by OTC Markets Group (OTCQX: OTCM) in its prominent OTCQX® Video Series. The series features interviews with senior executives of O...
Source: PR Newswire
Date: May, 18 2018 07:00
OTCQX And OTCQB Companies to Present At 2018 ROTH Conference
NEW YORK , March 8, 2018 /PRNewswire/ -- OTC Markets Group Inc.  (OTCQX: OTCM), operator of financial markets for 10,000 U.S. and global securities, today unveiled the list of OTCQX® Best Market and OTCQB® Venture Market presenting companies at the 30 th Annual ROTH Confe...
Source: PR Newswire
Date: March, 08 2018 10:00

 


Last 5 Days Trading Activity

DateOpen PriceClose PriceHighLowVolume
2018-12-14N/A0.09N/AN/A0
2018-12-13N/A0.09N/AN/A0
2018-12-120.090.090.090.0973,944
2018-12-110.090.090.090.094,030
2018-12-100.0570.0560.070.05667,423

Last 5 Days Short Activity

DateShort VolumeTotal VolumeShort PercentageShort Indicator
2018-12-1010,00067,42314.8317Cover
2018-12-0771,42379,22390.1544Short
2018-11-1922,700434,4235.2253Cover
2018-11-1620,000212,9009.3941Cover
2018-11-0510,00054,00018.5185Cover

* Cover Mode

Short Analysis provided by Squeeze Report. Get a complete short report on BNOEF.


About Bionomics Ltd. (OTC: BNOEF)

Logo for Bionomics Ltd. (OTC: BNOEF)

Bionomics is a global, clinical stage biopharmaceutical company leveraging its proprietary platform technologies to discover and develop a deep pipeline of novel drug candidates focused on the treatment of serious central nervous system disorders and on the treatment of cancer.

 

Contact Information

 

 

Current Management

  • Deborah Rathjen / CEO
  • Jack Moschakis / Company Secretary
  • Errol De Souza / Chairman
  • Alan Fisher /
  • Deborah Rathjen /
  • Peter Turner /
  • David Wilson /

Current Share Structure

  • Market Cap: $186,515,450 - 03/16/2018
  • Authorized: 481,952,066 - 09/18/2017
  • Issue and Outstanding: 481,952,066 - 09/18/2017

 


Recent Filings from (OTC: BNOEF)

Semi-Annual Report - Half Yearly Report and Accounts
Filing Type: Semi-Annual Report - Half Yearly Report and AccountsFiling Source: OTC Markets
Filing Date: February, 13 2018
Quarterly Report - Appendix 4C - quarterly
Filing Type: Quarterly Report - Appendix 4C - quarterlyFiling Source: OTC Markets
Filing Date: January, 31 2018
Quarterly Report - Appendix 4C - quarterly
Filing Type: Quarterly Report - Appendix 4C - quarterlyFiling Source: OTC Markets
Filing Date: October, 31 2017
Proxy Materials - Notice of Annual General Meeting/Proxy Form
Filing Type: Proxy Materials - Notice of Annual General Meeting/Proxy FormFiling Source: OTC Markets
Filing Date: October, 13 2017
Annual Report - Bionomics Annual Report 2017
Filing Type: Annual Report - Bionomics Annual Report 2017Filing Source: OTC Markets
Filing Date: October, 13 2017

 

 


Daily Technical Chart for (OTC: BNOEF)

Daily Technical Chart for (OTC: BNOEF)


Stay tuned for daily updates and more on (OTC: BNOEF)

It most certainly could but even more important is the recent overwhelming interest in the company. Check out Investors Hub and search on Twitter

More to come on (OTC: BNOEF)

Do your DD and if you choose, be ready to go!


 

The Research: All source information contained in this email is from the public sources mentioned below.

 

 
 

Thank you

DD Report
@DDReports

 

 


Disclaimer: DD Report publishes reports providing information on selected companies. DD Report is not a registered investment advisor or broker-dealer. This report is provided as an information service only, and the statements and opinions in this report should not be construed as an offer or solicitation to buy or sell any security. DD Report accepts no liability for any loss arising from an investors reliance on or use of this report. An investment in BNOEF is considered to be highly speculative and should not be considered unless a person can afford a complete loss of investment. DD Report has received no compensation for the publication and circulation of this report. DD Report does not own any shares of BNOEF and does not buy, sell, or trade any shares of BNOEF. This report contains forward-looking statements, which involve risks, and uncertainties that may cause actual results to differ materially from those set forth in the forward-looking statements. Copyright 2018 by DD Report. All rights reserved. Our Full Disclaimer: https://dd.report/disclaimer/